Regeneron Pharmaceuticals, Inc. (REGN)
787.91
+21.25
(+2.77%)
USD |
NASDAQ |
Mar 04, 16:00
780.00
-7.91
(-1.00%)
After-Hours: 18:11
Regeneron Pharmaceuticals Research and Development Expense (Annual) : 5.306B for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Amgen, Inc. | 6.974B |
| Gilead Sciences, Inc. | 5.688B |
| Johnson & Johnson | 14.83B |
| Eli Lilly & Co. | 13.34B |
| Merck & Co., Inc. | 12.51B |